H.E. Dr. Ahmed AlKhazraji serves as the Executive Director of the Healthy Living Unit at the Department of Health, a whole-of-government delivery unit with a mission to create the most active population, supported by a healthy food system, within a health-conscious society. Bringing together government entities, private sector partners, and communities, he is ‘hard-wiring’ prevention and wellbeing in Abu Dhabi through system-level changes that make healthy choices the default in citizens and residents’ everyday lives.

His immediate past role was the Acting Director-General of the Abu Dhabi Public Health Center, where he led and launched critical public health initiatives focused on preventing disease, prolonging life, and driving a culture of health and safety among Abu Dhabi’s citizens and residents, as well as emergency response operations related to infectious diseases, disasters, and crises. He has also served as the Executive Director of Strategy & Policy at the Department of Health, and Director of Health Affairs at the Abu Dhabi Executive Office.

Dr. AlKhazraji has over 15 years of health and healthcare experience across public and private sectors, and has been recognized for his successes in driving large-scale government initiatives, advancing critical health programs, and transforming organizations. He is a Fellow of the American College of Healthcare Executives (FACHE), and an alumnus of the UAE Prime Minister’s Office Government Executive Leaders program. He completed his doctorate, master’s, and bachelor’s degrees at the University of Southern California and Marquette University, in the United States.

Dr Fahad AL Zadjali, is currently the dean of Oman college of health sciences and previously as director of studies and research at Ministry of health in Oman and Faculty at Sultan Qaboos University. He had over 22 years experience in academia and involved in teaching medical, residents, nursing and biomedical science students at Sultan Qaboos University. Also he is in the education committee for medical residency program of clinical biochemistry program. Dr Fahad expertise is in the field of Medical science and study molecular mechanism of disease pathogenesis. His work is on non-alcoholic fatty liver disease, ulcerative colitis, renal cystogenesis and familial hypercholesterolemia. Dr Fahad is also responsible for genetic analysis of patients with familial dyslipidemia in the lipid clinic provided in the university hospital and also other in-born errors of metabolism. Dr Fahad was the vice dean for academic program for college of medicine and for research at Sultan Qaboos university. Currently, Dr Fahad is involved in national health research that governs clinical trials, healthy policy research and national surveys.

Francesco Cucca graduated cum laude in Medicine from the University of Cagliari in March 1985 and specialised in Paediatrics cum laude in June 1989. From June 1994 to December 1996 he was a research fellow at the Wellcome Trust for Human Genetics at the University of Oxford (UK). He then returned to Sardinia and set up his own research group.

From July 2011 to present he has been full Professor of Medical Genetics at the University of Sassari (Italy). From May 2009 to June 2019 he was the Director of the “Institute of Genetic and Biomedical Research” (IRGB) of the Italian National Research Council (CNR).

His research activity focuses on the genetic analysis of quantitative haematological and immunological traits and diseases, in order to find genetic overlaps ("coincident associations") with autoimmune and haematologoca disease that reveal biological mechanisms and suggest therapeutic targets. From January 2010 to date he has been PI of the SardiNIA study (https://irgb.cnr.it/projects/the-progeniasardinia-project-2/), mainly funded by the National Institute of Ageing (USA), which aims to determine individual trajectories and characteristics of the ageing process as well as longer-term health-related outcomes in a cohort of general population individuals visited every ~5 years since 2001. From May 2015 to April 2019 he has been the PI of the ImmunoAgeing project (https://www.immunoageing.eu/index), which was funded by the European Union's Horizon 2020 research and innovation funding programme, which aimed to describe the effects of ageing on individual trajectories of over 1000 immune traits in the SardiNIA cohort of ~8000 men and women aged 18-108 years, and how they are influenced by gender and genetic factors, and to understand the implications for health and longevity..

His research has resulted in over 300 peer-reviewed studies, some of which have been published in leading journals such as Nature, Science, Cell, the New England Journal of Medicine, and Nature Genetics.

Extened CV at: https://irgb.cnr.it/people/francesco-cucca/

Prof. Khalid Fakhro is the Chief of Research and Chair of the Precision Medicine Program at Sidra Medicine, the largest tertiary women and children’s hospital in Qatar. In this role, Dr Fakhro oversees >250 translational, clinical and implementation studies designed to advance diagnostic biomarker discovery and tailor personalized therapies for patients with rare and complex disease. In addition to his executive role, Dr Fakhro leads the Laboratory of Human Genetics and Genomics, which brings emerging genomic technologies from bench to bedside. Over the past decade, his group has sequenced thousands of Qatari and Middle Eastern genomes, leading gene discovery efforts for a wide range of rare disorders, as well as landmark studies on population structure, genome structural variation, disease multi-omics, and the role of Islamic ethics in genome research. His lab has been awarded competitive grants exceeding $11m to study population genetics, rare disease and Autism, and their discoveries have featured in high-impact journals worldwide. Dr Fakhro serves multiple leadership roles in Qatar’s biomedical ecosystem, including on the Board of Directors of the Qatar Precision Medicine Institute and of Diabetes Qatar, on Program Advisory Committees at several local universities, and as adjunct faculty at both Weill-Cornell Medicine and Hamad Bin Khalifa University, where he supervises Masters and PhD students in genomics and precision medicine.

Luigi Fontana is an internationally recognized physician scientist and one of the world’s leaders in the field of nutrition, metabolism and healthy longevity in humans. His pioneering studies on the effects of dietary restriction in humans have opened a new area of nutrition-related research that holds tremendous promise for the prevention of age-related chronic diseases and for the understanding of the biology of human aging.

Professor Fontana is the Leonard P. Ullmann Chair of Translational Metabolic Health at the Charles Perkins Centre, where he directs the Charles Perkins Centre Royal Prince Alfred Clinic and the Health for Life Research, Clinical & Educational Program. He is also a Professor of Medicine and Nutrition in the Faculty of Medicine and Health at the University of Sydney and a Clinical Academic in the Department of Endocrinology at the Royal Prince Alfred Hospital.

Professor Fontana was a Senior Scientist at the Italian NIH (ISS) and a Professor of Medicine and Nutritional Sciences at Washington University in St.Louis (USA), and co-director of the Longevity Research Program at Washington University. Fontana graduated with highest honors from the Verona University Medical School (1994), where he completed his internship and residency in Internal Medicine (1999). He also received a Ph.D. in Metabolism and Clinical Pharmacology from the University of Padua Medical School (2003). Professor Fontana has published over 180 manuscripts in prestigious journals including Science, Cell, New England Journal of Medicine, JAMA, BMJ, CA Clinical Journal cancer, Nature Reviews Mol Cell Biol, Cell Metabolism, Lancet Diabetes Endocrinol, Circulation, Journal American College of Cardiology, and PNAS ; 96.4% of his papers are in the top 10% most-cited journals (Google scholar total citations >39,000; h-index 90). He has been invited to present his work at international conferences and top medical schools and research institutes around the world, including Harvard University, Cambridge University, Yale University, Universitè Paris “Pierre et Marie Curie”, Max Plank Institute of Aging, Baylor College of Medicine, Buck Institute for Research on Aging, Spanish National Cancer Research Centre, National University of Singapore among others.

Dr. Fontana’s is the recipient of several prestigious awards, including the 2009 American Federation Aging Research (AFAR) Breakthroughs in Gerontology Award and the 2011 Glenn Award for Research in Biological Mechanisms of Aging, the 2016 Vincent Cristofalo Award of the American Federation Aging Research, 2021 Vice-Chancellor's Awards for Excellence of the University of Sydney, 2022 Honorary Member of the Italian Association of Hospital Gastroenterologists, 2022 Ordinary Non-resident Member of the Italian Academy of Medical and Surgical Sciences of the National Society of Sciences in Naples, and 2023 Ordinary Non- resident Member of of the Italian Pontanian Academy of Naples (founded in 1458). He was a Scientific Member of the Board of Directors of the American Aging Association (2014-2019), and since 2016, he is the Editor-in-Chief of ‘Nutrition and Healthy Aging’ and Associated Editor of ‘Geroscience’.

Professor Fontana believes that the time has come for a change in the conversation about chronic disease to a refreshed and repurposed model of health care, which emphasizes the power of mechanism based prevention and education to change potential to actual outcomes. Fontana is also an environmentalist. He wrote several highly-cited perspective articles and book chapters with Daniel Kammen, Walter Willett and Nicoletta Batini on the beneficial role of efficient use of energy and food in promoting human, environmental, and planetary health, and sustainable economic development. Fontana and colleagues believe that it is possible to substantially enhance human and environmental health, societal wealth and well-being, but this requires a profound transformation in the way we live, and a new prevention- and environment-centred healthcare, agricultural, industrial and economic system. They argues that most of the knowledge and technology to transform the world and begin a new industrial revolution already exist today. We only need to relinquish the idea of producing more energy, food, and other products at lower cost in favor of a new paradigm that opts for less but high-quality energy, food and materials for a healthier life and environment. They also claims that “both individual and societal wealth, happiness, and well-being do not depend merely on the acquisition of material goods and on economic growth, but are powered by our physical and psychological health, the quality of life and the richness of our social relationships, and foremost by the health of the environment that supports all life on earth, our Natural Capital that must be preserved”.

Maria P. Abbracchio is Full professor of pharmacology and neuroscientist at the University of Milan, Italy, where, from 2018-2024 she has also served as Deputy Rector with legal signature and Vice Rector for Research and Innovation. She earned her degree in Pharmacy in Milan and completed her training at the Medical School, University of Texas at Houston, USA, followed by a specialization in Toxicology, a PhD in Experimental Medicine in Rome, and post-doctoral research at University College London (UK). Her research focuses on innovative neuro-reparative therapies for major aging-associated neurodegenerative diseases. She is author/coauthor of more than 300 scientific publications, with a H index of 70 (highly cited scientist, Thompson Reuters). She has received many international Prizes, she is a member of Academia Europaea and in 2014 was awarded the title of Commander of the Highest Order of Merit of the Italian Republic by President Giorgio Napolitano. Recently, she has developed a strong interest in longevity (Co-President of the Milan Longevity Summit, and invited speaker at the Vatican Longevity Summit, 2026), in gender medicine and in the ethical application of AI in pharmacology and medicine (Vice President of the Ethical Research Committee of the University of Brescia since 2024; Co-founder of AlgoRadar, Milan, 2026).

• Graduated from Kasturba Medical College, India - in 2006
• Completed pediatric residence program, Arab Board in pediatric in 2013
• Completed fellowship in Genetic and Metabolic speciality in King Faisal specialist hospital and research center , Riyadh , Saudi Arabia
• Working as a genetic and metabolic consultant in Salmaniya Medical complex with more than 12 years of experience in evaluating , diagnosing and managing various genetic and metabolic disorders in pediatric and Adult age group
Clinical researcher on genetic and metabolic disorders
• A member of the Bahrain genome project

Dr. Valter Longo, PhD, is the Edna Jones Professor in Biological Sciences and Gerontology, at the USC Leonard Davis School of Gerontology, one of the oldest and leading centers for aging research. His laboratory studies the fundamental mechanisms of aging in yeast, rodents and humans by using genetics and biochemistry techniques with focus on the nutrient-response signal transduction pathways. This work led to the first identification of the role of the Tor-S6K pathway in longevity and healthspan extension. His laboratory has also discovered the effect of periodic fasting and fasting mimicking diets (FMD) on multi-system reprogramming and stem cell-dependent regeneration in mice, later translated into clinical trials to prevent and treat a range of age-related diseases. FMD cycles are effective in promoting obesity and diabetes regression and show promise for the treatment of autoimmune diseases and cancer.

Prof. Evelyne Bischof, MD, PhD, Dr. Evelyne Bischof is a clinician and a full professor. In addition, Dr. Bischof is the President of Healthy Longevity Medicine Society. Evelyne underwent her training at Harvard Medical School affiliated hospitals (Mass General. Beth Israel, Brigham's and Dana Farber), Columbia University and Basel University Hospital. Frequent keynote speaker at global conferences, such as Milken Institute event, ARDD, Arab Health, Longevity Investors Gstaad, Founder’s Forum, Future Health Summit UAE, China Daily summit etc. Her specialization lies in Internal Medicine and Medical Oncology and her scientific work focuses on healthy longevity medicine, AI and digital health with a research focus on oncology, preventative and precision medicine and gerontology. Prof. Bischof spent a decade practicing medicine, lecturing at medical schools and performing clinic and translational research in New York, Shanghai and Basel, Switzerland. She has extensive experience in scientific research and clinical practice at highly reputable institutions including the Fudan Cancer Institute and Hospital in Shanghai, Renji Hospital (Jiaotong University). Dr. Bischof has published over 180 peer-reviewed papers and is a member of the European Federation of Internal Medicine, the Royal Society of Medicine, the Swiss Society of Internal Medicine and more.

Dr. David L. Katz, MD, MPH, FACPM, FACP, FACLM is a board-certified specialist in Internal Medicine and Preventive Medicine/Public Health, known globally for expertise in chronic disease prevention, Lifestyle Medicine, Integrative Medicine, and nutrition. He earned his BA at Dartmouth College (1984); his MD at the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993).

Katz is the founder and former director of Yale University’s Yale-Griffin Prevention Research Center (1998-2019); Past President of the American College of Lifestyle Medicine; Founder of the non-profit True Health Initiative; Founder of Diet ID; and serves as a senior science advisor to Blue Zones, and the Institute for Healthier Living, Abu Dhabi. He is a Fellow of the American College of Preventive Medicine; the American College of Physicians; the American College of Lifestyle Medicine; and Morse College, Yale University.

The recipient of numerous awards for teaching, writing, research, clinical care, and contributions to public health, Katz has received three honorary doctorates.

He holds multiple US patents; has over 250 peer-reviewed publications; and has authored/co- authored 19 books to date including multiple editions of leading textbooks in nutrition, preventive medicine, and epidemiology.

He and his wife, Catherine S. Katz, PhD, live in Connecticut with their dogs and 2 horses. They have 5 adult children.

With a career spanning 20 years, Dr. Sirotin is an award-winning physician, thought leader and international speaker in Precision Lifestyle Medicine with a passion for advancing longevity science through local and international platforms. As the Chief Executive Officer at the Institute for Healthier Living Abu Dhabi, she leads groundbreaking initiatives that integrate advanced technology and precision diagnostics with cutting-edge lifestyle and longevity medicine to redefine personalized, preventive care.

As CEO, Dr. Sirotin has built partnerships with academic, public and private entities to help develop the field of Healthy Longevity Medicine. As the world's first government recognized longevity medicine facility, the Institute has established new global standards in Healthy Longevity Medicine with the Abu Dhabi Department of Health, with the hope of building a future where personalized enhanced healthspan is accessible to patients worldwide. Prior to establishing the Institute, for 10 years Dr. Sirotin served as Department Chair at Cleveland Clinic Abu Dhabi developing the Preventive Medicine programs in Executive Health and Lifestyle Medicine in the Cancer Center, in addition to the clinical team for the Office of Facilitated Access.

Dr. Sirotin is a Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine and Khalifa University. She previously held faculty positions at Weill Cornell Medical College and Albert Einstein College of Medicine. Dr. Sirotin’s awards include the UCSF Exceptional Physician Award and the Cleveland Clinic Abu Dhabi Women’s Professional Staff Association’s Physician of the Year Award. Dr. Sirotin also serves as the Council Secretary of the Healthy Longevity Medicine Society.

Dr. Sirotin’s expertise has been spotlighted at leading global forums including the Founders Longevity Forum, Milken Institute Summit, Aging Research and Drug Discovery Conference, Geneva College of Longevity Science, World Health Expo, and the American College of Lifestyle Medicine Conference. Her insights have also been featured by many regional and international media outlets, including CNN, Gulf Business, Aletihad, and the Abu Dhabi Media Office, highlighting her leadership in launching the world’s first regulated Healthy Longevity Medicine Centre and shaping the future of precision and longevity medicine.

Dr. Rebecca Robbins is an Assistant Professor in Medicine at Harvard Medical School and an Associate Scientist at the Brigham and Women’s Hospital. Her research is focused on uncovering the connection between the quantity and quality of sleep and various dimensions of waking success, from cognitive to physical and emotional health and well-being. Dr. Robbins has received funding from the National Institutes on Aging and the National Heart, Lung, and Blood Institute. Dr. Robbins is the Co-Principal Investigator of the Ramadan Health Study, a cohort study to understand sleep, light exposure, meal timing, and health during Ramadan in the United Arab Emirates. Dr. Robbins has published more than 100 peer-reviewed articles and 20 encyclopedia chapters. Dr. Robbins is Co Author of Sleep for Success! Dr. Robbins makes frequent television appearances, including the Today Show, Live! with Kelly Ripa and Ryan Seacrest, and Good Morning America. Dr. Robbins has held teaching positions at Harvard College, the Harvard TH Chan School of Public Health and the Weill Cornell Medical College in Doha, Qatar.

Dr. Andrea Maier is Oon Chiew Seng Professor in Medicine, NUS Academy of Healthy Longevity, National University of Singapore and Professor of Gerontology, Human Movement Sciences VU Amsterdam after serving from 2016 to early 2021 as Divisional Director at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia. She graduated in Medicine from the University of Lübeck, Germany, was registered 2009 in The Netherlands as Specialist in Internal Medicine-Geriatrics and was appointed Full Professor of Gerontology at Vrije Universiteit Amsterdam (The Netherlands) in 2013. Andrea B. Maier is an authority in geroscience and precision geromedicine with more than 500 peer reviewed publications (H index 92, i10 index 382). She is invited member and advisor of international academic and health policy committees and funding agencies, including the World Health Organization evaluating the United Nations Decade of Healthy Ageing and Hevolution. She is the past Founding President of the Healthy Longevity Medicine Society and serves as selected Member of The Royal Holland Society of Sciences and Humanities, Fellow of the Atria Academy of Science and Medicine, and Board of the Academy for Health and Lifespan Research. In 2023, she co-founded the NUS Academy for Healthy Longevity to conduct, teach and disseminate Geroscience and Precision Geromedicine. To bring highest evidence-based Precision Geromedicine to clinical practice, she founded Chi Longevity - Asias first evidence based Precision Geromedicine clinics – in 2022 and established Maier’s Longevity in 2024 in The Netherlands.

Jose Galgani, PhD, is an Associate Professor in the Department of Medical Sciences at Khalifa University. His research focuses on human energy metabolism and the physiological and behavioral factors underlying individual susceptibility to weight gain. His work integrates approaches including indirect calorimetry, body composition, and the study of eating behavior to understand variability in energy expenditure, substrate oxidation, and responses to nutritional challenges. He has particular interest in translating metabolic phenotyping into strategies for the prevention and management of obesity.

Dr. Maryam Al Ali is a Family Medicine Consultant and Division Chief of Family Medicine and Occupational Medicine at Sheikh Khalifa Medical City (SKMC), Abu Dhabi. She is a Medical Director at Zayed Herbal Complex for Traditional Medicine and Herbal Research. A pioneer in the field of lifestyle medicine in the United Arab Emirates, Dr. AlAli is the first Emirati physician to be licensed in Lifestyle Medicine by the Department of Health (DoH) Abu Dhabi. She is a Certified Lifestyle Medicine Physician and a Blue Zones Certified Physician, with a particular interest in healthy longevity, chronic disease prevention, population health, and wellbeing promotion. Dr. AlAli also serves as a Founding Board Member of the Emirates Lifestyle and Longevity Society, contributing to the advancement of lifestyle medicine and healthy ageing initiatives across the UAE. Her areas of expertise include family medicine, lifestyle medicine, integrative healthcare, clinical governance, and healthcare regulation. Dr. AlAli leads initiatives that integrate evidence-based lifestyle and traditional medicine approaches into modern healthcare systems, while fostering international collaborations that support innovation, patient-centred care, and sustainable health system transformation.

Dr Ayman Al-Hendy is currently a Professor (Tenure) and Vice Chair (Research), Department of Obstetrics and Gynecology, Advisor to Dean of Medicine, Pritzker School of Medicine, University of Chicago (UC). Dr. Al-Hendy is also professor and chair of Dept of Medical Sciences, Khalifa University, Abu Dhabi, United Arab Emirates. Dr. Al-Hendy is a Gynecologist and minimally-invasive Surgeon at UC Medical Center, Chicago, Illinois with a busy practice that focuses on serving women with symptomatic uterine fibroids and premature ovarian insufficiency. Dr. Al-Hendy graduated from Banha Faculty of Medicine, Zagazig University, Banha, Egypt in 1986. After 1 year of internship at Banha University Hospital, he headed to Finland to earn his PhD in Molecular Medicine from University of Turku, Turku, Finland. He then gained additional postdoctoral training in gene/cell therapy and clinical molecular genetics at McMaster University and McGill University in Canada, before completing clinical residency training in Obstetrics and Gynecology at University of Saskatchewan and fellowship training in laparoscopic surgery at Toronto University, both in Canada. Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. In United States of America, Dr. Al-Hendy held various faculty positions at University of Texas Medical Branch, Galveston, Texas, Meharry Medical College/Vanderbilt University, Nashville, Tennessee, and Medical College of Georgia, Augusta, Georgia, before moving to Chicago, Illinois.

Dr. Al-Hendy utilizes the methods of basic, translational, clinical and community research to address important medical diseases. Dr. Al-Hendy medical research interests focus on developing novel therapies including gene and stem cell therapy for Premature Ovarian insufficiency, Endometriosis, and particularly Uterine Fibroids. He has championed the use of specific natural fertility-friendly non-hormonal compounds such as green tea extracts (Epigalcatchin Gallate, EGCG) and vitamin D for prevention and treatment of uterine fibroids. He was first (2010) to introduce hypovitaminosis D as a risk factor to development of uterine fibroids and a contributing reason of why they are much more prevalent in women of color. An observation that has been confirmed subsequently by numerous publications globally.

Dr. Al-Hendy also pioneered (2009) the concept of enhancing ovarian folliculogenesis via direct intra-ovarian injection of appropriate augmenting biologics. After ample preclinical work on utilizing human bone marrow mesenchymal stem cells or its exosomes (naïve or enhanced) to treat representative animal models, Dr. Al-Hendy has started clinical trials to translate such innovative approach to women suffering from premature ovarian insufficiency as well as other ovarian causes of infertility.

In 2010, Dr. Al-Hendy was awarded the American Society of Reproductive Medicine’s (ASRM) 2010 Ira and Ester Rosenwaks Award for his significant contribution to the field of translational Reproductive Biology. In 2014 he received the alpha Omega alpha clinician scientist of the year award by the Medical Honor Society and in 2015 the President Achievement Award as well as Rogerio A. Lobo Award from the Society of reproductive Investigations (SRI). Dr. Al-Hendy research has been continuously funded by various agencies since 2002 including NIH (NICHD, NIEHS, NIMHD, ODS, OD, NCRR), USDA, and other national and international organizations. He has served as Chair of the NIH Integrative Clinical Endocrinology and Reproduction (ICER) IRG 2013-2015 and also serves on numerous other committees with organizations such NIH, ASRM, SRI and as Co-Editor-in-Chief of The SRI Journal, Reproductive Sciences as well as on several editorial boards of high impact journals. Dr. Al-Hendy has been elected as SRI 71st President. He has published more than 311 peer reviewed medical articles in high tier peer reviewed scientific journals with more than 16,000 citations in the understudied area of non-malignant (benign) gynecology (H-index 71), above 400 presentations in national and international meetings, and has edited 5 medical books.

• MIT Professor of Chemistry specialising in peptide therapeutics and drug-delivery technologies
• Leads of Amide Technologies
• Leads leader in ultrafast peptide synthesis, intracellular delivery and chemical biology innovation
• Leads flow-based peptide synthesis, enabling rapid production of long and complex peptides
• Leads extensively in top journals and collaborates widely with major pharmaceutical companies
• Leads the Research & Development of peptides

With over two decades of dedicated services in healthcare leadership, Dr. Aisha has emerged as a transformative force in public health, wellbeing policies, and sustainable healthcare development. By merging clinical expertise with strategic administrative proficiency, she has played a pivotal role in shaping healthcare excellence in the United Arab Emirates (UAE) and beyond.

Dr. Aisha has been dedicated professional at Primary Health Care Center (PHCC) since 2003, progressing from clinical roles to executive leadership. In 2015, she transitioned into directorship in Al Ittihad PHCC, and later in Muhaisnah PHCC. Since 2021, Dr. Aisha has held the role of Director of the Wellbeing and Sustainability Development Office in Public Health Sector, driving national and global wellbeing policies. Under her visionary leadership, the UAE has emerged as a global pioneer in health promotion – a legacy underscored by the historic adoption of the UAE Wellbeing Resolution at the 75th World Health Assembly (2022 &2023), marking a transformative milestone in global health governance.

Her academic background in Doctor of Dental Surgery and Master of Science in Hospital Management equipped her with a unique ability to bridge policy and practice, blending clinical expertise with advanced healthcare administration.

Key Achievement & Global impact

• Official spokesperson and representative of the Ministry at multiple events and conferences, including the Arab Health Congress, and recorded official podcast episodes for the Ministry of Health and Prevention.
• Pioneer in Architect of Wellbeing Policies
• International representation:
  • Country Delegate to the World Health Assembly (2022-2025), delivering UAE statements on global health priorities.
  • Vice Chair of the UAE National Committee for Health & Wellbeing (2022)
  • Delegate for CEDAW (UN, Geneva, 2022), advocating for gender equality in health.
• Accreditations & Quality Leadership: Successfully secured JCI and Baby-Friendly accreditations for multiple health care centers.
• Award-Winning Contributions:
  • Extraordinary Contributions Award (COVID- 19 Response, 2022) – Arab Hospital Federation (Medhealth Cairo)
  • Certified Recognition for preserving employee health at the UAE Prime Ministry Office (2021)
• Completed the Fundamentals of International Ceremonial & VIP Protocol course at the School of Washington, strengthening diplomatic and ceremonial expertise – skills instrumental facilitating high-level engagements and welcoming global prime ministers during COP28.
• A member in multiple committees including (National Human-Trafficing committee, National Wellbeing Committee, etc)

A Future-Driven Vision

With an unwavering commitment to health equity, sustainable development, and global well-being, Dr. Aisha continues to influence policy development that enhances quality of life, foster resilience and position the UAE as a leader in 21st – century healthcare innovation. Her journey reflects a powerful blend of expertise, leadership, and passion for creating a healthier future for all.